{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:16:36Z","timestamp":1761718596375,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/National Center for Advancing Translational Science (NCATS) UCLA CT","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U01AI113315-02"],"award-info":[{"award-number":["5U01AI113315-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["5U01AI113315-02"],"award-info":[{"award-number":["5U01AI113315-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL112990\u201301"],"award-info":[{"award-number":["R01 HL112990\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180281","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T17:37:34Z","timestamp":1499449054000},"page":"e0180281","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-5390","authenticated-orcid":true,"given":"Michael Y.","family":"Shino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Samuel","family":"Weigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Palchevskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariss","family":"Derhovanessian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Sayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aric L.","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2011.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report\u20142011","volume":"30","author":"JD Christie","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e0117618","DOI":"10.1371\/journal.pone.0117618","article-title":"Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy","volume":"10","author":"E Crespo","year":"2015","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction","volume":"30","author":"M Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e318286e076","article-title":"Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?","volume":"95","author":"SE Verleden","year":"2013","journal-title":"Transplantation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1164\/rccm.201306-1155OC","article-title":"Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction","volume":"189","author":"JL Todd","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e31822bf790","article-title":"Survival determinants in lung transplant patients with chronic allograft dysfunction","volume":"92","author":"GM Verleden","year":"2011","journal-title":"Transplantation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TP.0b013e3181852f02","article-title":"Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies","volume":"86","author":"CM Burton","year":"2008","journal-title":"Transplantation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria","volume":"21","author":"M Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200706-951OC","article-title":"Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation","volume":"177","author":"AR Glanville","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":"Risk factors for bronchiolitis obliterans: a systematic review of recent publications","volume":"21","author":"LD Sharples","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2009.04.022","article-title":"Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1","volume":"28","author":"CM Burton","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/TP.0b013e3181641df9","article-title":"Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies","volume":"85","author":"CM Burton","year":"2008","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1600-6143.2011.03849.x","article-title":"Spirometrically Significant Acute Rejection Increases the Risk for BOS and Death After Lung Transplantation","volume":"12","author":"WA Davis","year":"2012","journal-title":"Am J Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.tp.0000181161.60638.fa","article-title":"The significance of a single episode of minimal acute rejection after lung transplantation","volume":"80","author":"RR Hachem","year":"2005","journal-title":"Transplantation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.200302-165OC","article-title":"Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis","volume":"170","author":"PM Hopkins","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome","volume":"159","author":"AN Husain","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1600-6143.2005.00953.x","article-title":"Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome","volume":"5","author":"AP Khalifah","year":"2005","journal-title":"Am J Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(97)70144-2","article-title":"Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation","volume":"114","author":"TJ Kroshus","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref19","first-page":"1200","article-title":"Risk factors for the development of obliterative bronchiolitis after lung transplantation","volume":"15","author":"RE Girgis","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000478-199305000-00008","article-title":"Lymphocytic bronchitis\/bronchiolitis in lung allograft recipients","volume":"17","author":"SA Yousem","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1053-2498(99)00047-9","article-title":"Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation","volume":"18","author":"A El-Gamel","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"ref22","first-page":"1255","article-title":"Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors","volume":"17","author":"D Heng","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"ref23","article-title":"Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation","author":"M Sato","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201305-0861OC","article-title":"CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction","volume":"188","author":"MY Shino","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.171.9.4844","article-title":"Role of CXCL9\/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection","volume":"171","author":"JA Belperio","year":"2003","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.169.2.1037","article-title":"Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome","volume":"169","author":"JA Belperio","year":"2002","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"S Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"ref29","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group","volume":"15","author":"SA Yousem","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1600-6143.2009.02635.x","article-title":"Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome","volume":"9","author":"SS Weigt","year":"2009","journal-title":"Am J Transplant"},{"key":"ref31","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation","volume":"12","author":"JD Cooper","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sato MS, T.; Waddell, T.K.; Singer, L.G.; Keshavjee, S. (2013) Diagnosis of Restrictive Allograft Syndrome (RAS) without Using Total Lung Capacity. ISHLT 33rd Annual Meeting and Scientific Sessions Abstract.","DOI":"10.1016\/j.healun.2013.01.1029"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.201210-1831OC","article-title":"Acute fibrinoid organizing pneumonia after lung transplantation","volume":"187","author":"M Paraskeva","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"KE Cole","year":"1998","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"M Loetscher","year":"1996","journal-title":"J Exp Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T15:45:32Z","timestamp":1659195932000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180281"}},"subtitle":[],"editor":[{"given":"Udai P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180281","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,7,7]]}}}